Building a Patient Advocacy Organization to Accelerate Clinical Development and Community Impact
A clinical-stage biotechnology company developing a therapy for a rare disease faced a significant challenge: there was no dedicated patient advocacy organization serving the community. Without a central resource for
Building a Patient-Centered Advocacy Strategy for the Chronic Kidney Disease Community
A pharmaceutical sponsor sought to strengthen its engagement with the chronic kidney disease (CKD) community and establish a more strategic, patient-centered approach to advocacy. The organization recognized the need for
Creating a Trusted Patient Community to Support Clinical and Commercial Success
A sponsor developing therapies for IgG4-related disease (IgG4-RD) faced a critical engagement challenge: no established patient advocacy organization existed to educate, engage, or mobilize patients living with the condition. Without
Idiopathic Pulmonary Fibrosis Clinical Trial Recruitment
A sponsor conducting a Phase 2 clinical trial in Idiopathic Pulmonary Fibrosis (IPF) faced significant enrollment challenges driven by disease burden, study complexity, and patient hesitation around trial participation. To
Rare Autoimmune Disease Clinical Trial Recruitment
A rare autoimmune disease clinical trial had experienced significant enrollment delays despite being open for recruitment for two years. After 24 months, only three participants had enrolled, while a 48%
Global Disease Awareness for Rare Blood Cancer Therapy Launch
As an established biopharmaceutical company prepared for the global launch of a new rare blood cancer therapy, it sought to strengthen awareness of its leadership in the disease area while
Increasing Patient Recruitment for Rare Neurological Disease Phase-2 Clinical Trials
A pharmaceutical sponsor conducting a Phase 2 clinical trial for a rare neurological disease was experiencing a significant decline in patient recruitment after more than a year of active enrollment
Patient Storytelling Drives Chronic Pain Advocacy Success
A pharmaceutical company with an FDA-approved non-opioid treatment for chronic pain faced a significant market access challenge when the Centers for Medicare & Medicaid Services (CMS) proposed a reimbursement policy
Gene Therapy Trial Awareness Through Patient Engagement
A clinical-stage gene therapy company developing a potential treatment for a neurological condition sought to increase awareness of its clinical trial among patients, caregivers, and healthcare professionals. While the study
